**Due to the COVID-19 Pandemic we may experience unusually high call volumes. If you receive a network busy signal please continue to try your call throughout the day or you may email your report to: email@example.com**
ABRAXANE, BARACLUDE, COUMADIN, DAKLINZA, ELIQUIS, EMPLICITI, EVOTAZ, IDHIFA, INREBIC, ISTODAX, NULOJIX, ONUREG, OPDIVO, ORENCIA, POMALYST, REBLOZYL, REVLIMID, REYATAZ, SPRYCEL, SUSTIVA, THALOMID, VIDAZA, YERVOY, ZEPOSIA are trademarks of Bristol-Myers Squibb Company.
US Pharmaceuticals Medical Affairs
P.O. Box 4500, Princeton, NJ 08543-4500
We need to verify that you are a U.S. Healthcare Professional to view this website.
Please select the option below
that best describes you:
You are now leaving the Bristol-Myers Squibb Medical Information Online U.S. website.
Do you wish to continue?
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.